Uncategorized
RXi Pharmaceuticals and EyeGate Pharma Partner For Noninvasive Ocular Delivery of RNAi Therapeutics
RXi Pharmaceuticals Corporation (Worcester, MA) and
EyeGate Pharma (Waltham, MA) have announced a partnership
to deliver ocular RNAi therapeutics to treat retinal
disorders. Each party will contribute technology, expertise,
and resources to the collaboration, the companies
announced in a news release. Terms of the deal...